ArticleVaccines2025

Counterfactual Groups to Assess Vaccine or Treatment Efficacy in HIV Prevention Trials in High-Risk Populations in Uganda.

Andrew Abaasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.